creatine has been researched along with Thrombopenia in 11 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the present study was to investigate the risk factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy." | 7.75 | Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy. ( Fukao, A; Goto, C; Itoh, Y; Kasahara, S; Matsuura, K; Murakami, N; Niwa, T; Sakakibara, S; Suzuki, A; Yasuda, M, 2009) |
| "We prospectively studied 15 patients suffering from acute heparin-induced thrombocytopenia (HIT) type II with and without thromboembolic events and 4 patients with anamnestically known HIT type II recurrently requiring thromboprophylaxis in order to develop new therapeutic strategies by subcutaneous recombinant hirudin administration." | 7.70 | A new therapeutic option by subcutaneous recombinant hirudin in patients with heparin-induced thrombocytopenia type II: a pilot study. ( Harenberg, JF; Heene, DL; Hoffmann, I; Hoffmann, U; Huhle, G; Liebe, V, 2000) |
| " The results of our study show that the most cardinal clinical and laboratory features of Crimean-Congo hemorrhagic fever are - acute beginning of disease, high fever, intoxication and hemorrhagic symptoms, thrombocytopenia, high level of aminotransferases and creatine." | 3.81 | EPIDEMIOLOGY, CLINICAL AND LABORATORY FEATURES OF CRIMEAN-CONGO HEMORRHAGIC FEVER IN GEORGIA. ( Mikadze, I; Vashakidze, E, 2015) |
| "The aim of the present study was to investigate the risk factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy." | 3.75 | Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy. ( Fukao, A; Goto, C; Itoh, Y; Kasahara, S; Matsuura, K; Murakami, N; Niwa, T; Sakakibara, S; Suzuki, A; Yasuda, M, 2009) |
| "We prospectively studied 15 patients suffering from acute heparin-induced thrombocytopenia (HIT) type II with and without thromboembolic events and 4 patients with anamnestically known HIT type II recurrently requiring thromboprophylaxis in order to develop new therapeutic strategies by subcutaneous recombinant hirudin administration." | 3.70 | A new therapeutic option by subcutaneous recombinant hirudin in patients with heparin-induced thrombocytopenia type II: a pilot study. ( Harenberg, JF; Heene, DL; Hoffmann, I; Hoffmann, U; Huhle, G; Liebe, V, 2000) |
| " Based on this experience, we derived a lepirudin dosing regimen, which was prospectively evaluated treating 15 HIT patients between March 2007 and February 2008." | 2.74 | Dosing lepirudin in patients with heparin-induced thrombocytopenia and normal or impaired renal function: a single-center experience with 68 patients. ( Alberio, L; Lämmle, B; Tschudi, M, 2009) |
| " Argatroban dosage patterns, aPTTs and platelet count responses, and 37-day outcomes (death, amputation, new thrombosis, major bleeding) were summarised for patients stratified by age (65-74 years [n = 31]; 75-84 years [n = 26]; >/=85 years [n = 5]) to identify possible age-related trends." | 2.73 | Argatroban anticoagulation for heparin-induced thrombocytopenia in elderly patients. ( Bartholomew, JR; Hursting, MJ; Pietrangeli, CE, 2007) |
| "He had no disorders that could induce microangiopathic hemolytic anemia other than diabetic microangiopathy." | 1.29 | Case report: diabetic microangiopathic hemolytic anemia and thrombocytopenia with antiphospholipid syndrome. ( Daidoh, H; Ishizuka, T; Morita, H; Suwa, T; Takeda, N; Yasuda, K, 1996) |
| "To investigate the possible effect of preeclampsia on erythropoietin metabolism, we measured plasma and urine erythropoietin concentrations and complete blood count in 19 women with preeclampsia and nine healthy gravidas." | 1.28 | Erythropoietin in preeclampsia. ( Gonzales, E; Kaupke, CJ; Powers, DR; Vaziri, ND, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vashakidze, E | 1 |
| Mikadze, I | 1 |
| Tschudi, M | 1 |
| Lämmle, B | 1 |
| Alberio, L | 1 |
| Niwa, T | 1 |
| Suzuki, A | 1 |
| Sakakibara, S | 1 |
| Kasahara, S | 1 |
| Yasuda, M | 1 |
| Fukao, A | 1 |
| Matsuura, K | 1 |
| Goto, C | 1 |
| Murakami, N | 1 |
| Itoh, Y | 1 |
| Lee, JH | 2 |
| Choi, MS | 1 |
| Gwak, GY | 1 |
| Koh, KC | 1 |
| Paik, SW | 1 |
| Yoo, BC | 1 |
| Bartholomew, JR | 1 |
| Pietrangeli, CE | 1 |
| Hursting, MJ | 1 |
| Griffiths, WJ | 1 |
| Fitzpatrick, M | 1 |
| Morita, H | 1 |
| Suwa, T | 1 |
| Daidoh, H | 1 |
| Takeda, N | 1 |
| Ishizuka, T | 1 |
| Yasuda, K | 1 |
| Gattinara, M | 1 |
| Lomater, C | 1 |
| Gerloni, V | 1 |
| Mazzotti, J | 1 |
| Fantini, F | 1 |
| Huhle, G | 1 |
| Hoffmann, U | 1 |
| Hoffmann, I | 1 |
| Liebe, V | 1 |
| Harenberg, JF | 1 |
| Heene, DL | 1 |
| Kaupke, CJ | 1 |
| Vaziri, ND | 1 |
| Powers, DR | 1 |
| Gonzales, E | 1 |
| Larsson, SO | 1 |
| Hedner, U | 1 |
| Nilsson, IM | 1 |
2 trials available for creatine and Thrombopenia
| Article | Year |
|---|---|
Dosing lepirudin in patients with heparin-induced thrombocytopenia and normal or impaired renal function: a single-center experience with 68 patients.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Blood Cell Count; Blood Platelets; Creatine; Dose-Re | 2009 |
Argatroban anticoagulation for heparin-induced thrombocytopenia in elderly patients.
Topics: Aged; Aged, 80 and over; Anticoagulants; Arginine; Creatine; Female; Heparin; Humans; Male; Partial | 2007 |
9 other studies available for creatine and Thrombopenia
| Article | Year |
|---|---|
EPIDEMIOLOGY, CLINICAL AND LABORATORY FEATURES OF CRIMEAN-CONGO HEMORRHAGIC FEVER IN GEORGIA.
Topics: Adolescent; Adult; Aged; Animals; Antiviral Agents; Arachnid Vectors; Aspartate Aminotransferases; B | 2015 |
Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Anti-Bacterial Agents; Cohort Stud | 2009 |
[Clinical features and predictive factors of acute hepatitis A complicated with acute kidney injury].
Topics: Acute Disease; Acute Kidney Injury; Adult; Age Factors; Alanine Transaminase; Aspartate Aminotransfe | 2010 |
The effect of age on the creatine in red cells.
Topics: Aging; Anemia, Hemolytic, Autoimmune; Anemia, Hypochromic; Anemia, Macrocytic; Creatine; Erythrocyte | 1967 |
Case report: diabetic microangiopathic hemolytic anemia and thrombocytopenia with antiphospholipid syndrome.
Topics: Adult; Anemia, Hemolytic; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Creatine; Diabete | 1996 |
Cyclosporin in pediatric rheumatology; a seven years experience.
Topics: Adolescent; Adult; Antirheumatic Agents; Arthritis, Juvenile; Child; Child, Preschool; Creatine; Cyc | 1994 |
A new therapeutic option by subcutaneous recombinant hirudin in patients with heparin-induced thrombocytopenia type II: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Antibodies; Arterial Occlusive Diseases; Creatine; Female; Hematoma; | 2000 |
Erythropoietin in preeclampsia.
Topics: Adult; Albuminuria; Blood Cell Count; Blood Pressure; Creatine; Erythropoietin; Female; Humans; Pre- | 1991 |
[Acute uremia and intravasal coagulation].
Topics: Acute Kidney Injury; Blood Coagulation Factors; Creatine; Fibrinogen; Glomerulonephritis; Humans; Ne | 1971 |